Key facts
- Cala Health’s last known valuation is $150.0M (Mar 2025).
- It has raised $262.6M across 5 recorded rounds; the latest was Early Stage VC ($48.2M) in Nov 2024.
- Notable investors include Alumni Ventures, GV, Lux Capital, University of California, Pegasus Tech Ventures — 38 tracked in total.
- Cala Health has filed 5 Form Ds with the SEC since 2016, most recently Dec 2024 ($48.2M sold to 41 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Cala Health
Funding rounds
5 roundsAbout Cala Health
Developer of neuromodulation devices designed to optimize the standard of care for chronic diseases. The company's wearable device merges innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, enabling patients to reduce tremors and ensure relief.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2013
- Employees
- 102
- Website
- calahealth.com/
- Ownership
- Privately Held (backing)
Cala Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cala Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cala Health in its N-PORT filings yet. We sweep new filings monthly.